We are live on ! Find out more
AVA

Atlas Venture Advisors Portfolio holdings

AUM $122M
1-Year Est. Return 26.28%
This Fund
S&P 500
This Quarter Est. Return
-4.17%
1 Year Est. Return
-26.28%
3 Year Est. Return
-22.79%
5 Year Est. Return
-46.44%
10 Year Est. Return
–
AUM
$463M
AUM Growth
-$20.9M
Cap. Flow
-$735K
Cap. Flow %
-0.16%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
LRMR icon
Larimar Therapeutics
LRMR
+$735K

Sector Composition

Rank Sector Weight
1 Communication Services 52.69%
2 Consumer Discretionary 47.31%
3 Healthcare 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IAS
1
DELISTED
Integral Ad Science
IAS
$237M 51.19%
22,722,770
– –
DKNG icon
2
DraftKings
DKNG
$11.4B
$219M 47.31%
5,894,409
– –
ROKU icon
3
Roku
ROKU
$21.1B
$4.29M 0.93%
57,707
– –
SNAP icon
4
Snap
SNAP
$7.32B
$2.64M 0.57%
245,559
– –
LRMR icon
5
Larimar Therapeutics
LRMR
$416M
– –
-112,184
Closed -$735K

Similar funds

RCWM
Red Crane Wealth Management San Francisco, California $122M AUM 14.77% 1-Year Est. Return
CCM
CFO Capital Management Fairfield, Connecticut $121M AUM
SO
Sierra Ocean Ripon, California $122M AUM 16.19% 1-Year Est. Return
MAM
Mirabaud Asset Management London, United Kingdom $121M AUM 20.69% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $122M AUM 67.29% 1-Year Est. Return
VAM
Valliance Asset Management Central, Hong Kong $122M AUM 362.1% 1-Year Est. Return
TCM
TT Capital Management Coto De Caza, California $121M AUM 1.94% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Atlas Venture Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Atlas Venture Advisors held 5 positions worth $463M, down 4.3% from $484M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Atlas Venture Advisors's Q4 2024 filing shows 1 closed position. The largest sale was Larimar Therapeutics, an estimated $735K.

By sector, the portfolio is most concentrated in Communication Services at 53% of assets, up from 52% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Atlas Venture Advisors fully exited Larimar Therapeutics in Q4 2024, selling an estimated $735K.
  • Atlas Venture Advisors's ten largest holdings make up 100% of its $463M portfolio in Q4 2024.
  • Atlas Venture Advisors opened 0 new positions and closed 1 in Q4 2024.
  • Atlas Venture Advisors's portfolio value fell 4.3% quarter-over-quarter to $463M.

Based on Atlas Venture Advisors's 13F filing for Q4 2024, filed 11 Feb 2025.